The role of progesterone and estrogen receptors in treatment choice after endometriosis surgery: A cross-sectional study

Abstract Background: The lack of improvement in some endometriotic people's pain after surgery even while using hormone treatment may suggest an inappropriate response to routine hormonal therapies. Objective: This study aimed to determine a cut-off point for selecting the most appropriate trea...

Full description

Saved in:
Bibliographic Details
Main Authors: Tahereh Poordast, Saeed Alborzi, Ziba Kiani, Navid Omidifar, Elham Askary, Kefayat Chamanara, Mansoureh Shokripour, Alimohammad Keshtvarz Hesam Abadi
Format: Article
Language:English
Published: Shahid Sadoughi University of Medical Sciences 2024-09-01
Series:International Journal of Reproductive BioMedicine
Subjects:
Online Access:https://doi.org/10.18502/ijrm.v22i7.16970
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850265413037850624
author Tahereh Poordast
Saeed Alborzi
Ziba Kiani
Navid Omidifar
Elham Askary
Kefayat Chamanara
Mansoureh Shokripour
Alimohammad Keshtvarz Hesam Abadi
author_facet Tahereh Poordast
Saeed Alborzi
Ziba Kiani
Navid Omidifar
Elham Askary
Kefayat Chamanara
Mansoureh Shokripour
Alimohammad Keshtvarz Hesam Abadi
author_sort Tahereh Poordast
collection DOAJ
description Abstract Background: The lack of improvement in some endometriotic people's pain after surgery even while using hormone treatment may suggest an inappropriate response to routine hormonal therapies. Objective: This study aimed to determine a cut-off point for selecting the most appropriate treatment based on the hormone receptors of endometriotic lesions. Materials and Methods: In this cross-sectional study, by reviewing the medical records of participants and testing their archive samples and phone interviews (if needed), 86 symptomatic women after endometriosis surgery who were operated into governmental hospitals, Shahid Faghihi and Hazrate Zeinab Shiraz Iran were enrolled between March 2017 and March 2019. Women were divided into 2 groups: responsiveness (n = 73 for dysmenorrhea, n = 60 for dyspareunia) to medical treatment and surgery, and unresponsiveness (n = 13, n = 7). We examined the pathological slides of 86 women to determine the amount of hormone receptors and the relationship between the type of medical treatment and the level of hormone receptors on pain relief within 1 yr after surgery. Results: Based on the receiver operating characteristic curve, dysmenorrhea in the presence of tissue estrogen receptors > 60% (p = 0.1065), and dyspareunia in the presence of tissue progesterone receptors > 80% (p = 0.0001) responded well to medical treatment after surgery. In the presence of endometrioma-dysmenorrhea showed the best response to oral contraceptive pills (69.4%), while in deep infiltrative endometriosis-dyspareunia showed the best response to progesterone treatment (75%). Conclusion: Prescribing an appropriate hormone therapy based on a specific immunohistochemistry staining pattern can improve the life quality of postoperative endometriosis individuals.
format Article
id doaj-art-334a991393bf4f55a2d4e47f0eeb2112
institution OA Journals
issn 2476-4108
2476-3772
language English
publishDate 2024-09-01
publisher Shahid Sadoughi University of Medical Sciences
record_format Article
series International Journal of Reproductive BioMedicine
spelling doaj-art-334a991393bf4f55a2d4e47f0eeb21122025-08-20T01:54:26ZengShahid Sadoughi University of Medical SciencesInternational Journal of Reproductive BioMedicine2476-41082476-37722024-09-0122756757810.18502/ijrm.v22i7.16970ijrm.v22i7.16970The role of progesterone and estrogen receptors in treatment choice after endometriosis surgery: A cross-sectional studyTahereh Poordast0Saeed Alborzi1Ziba Kiani2Navid Omidifar3Elham Askary4Kefayat Chamanara5Mansoureh Shokripour6Alimohammad Keshtvarz Hesam Abadi7 Department of Obstetrics and Gynecology, School of Medicine, Infertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Department of Obstetrics and Gynecology, School of Medicine, Laparoscopy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Department of Obstetrics and Gynecology, School of Medicine, Maternal-Fetal Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Department of Obstetrics and Gynecology, School of Medicine, Maternal-Fetal Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Department of Obstetrics and Gynecology, School of Medicine, Infertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Department of Biostatistics, Shiraz University of Medical Sciences, Shiraz, Iran.Abstract Background: The lack of improvement in some endometriotic people's pain after surgery even while using hormone treatment may suggest an inappropriate response to routine hormonal therapies. Objective: This study aimed to determine a cut-off point for selecting the most appropriate treatment based on the hormone receptors of endometriotic lesions. Materials and Methods: In this cross-sectional study, by reviewing the medical records of participants and testing their archive samples and phone interviews (if needed), 86 symptomatic women after endometriosis surgery who were operated into governmental hospitals, Shahid Faghihi and Hazrate Zeinab Shiraz Iran were enrolled between March 2017 and March 2019. Women were divided into 2 groups: responsiveness (n = 73 for dysmenorrhea, n = 60 for dyspareunia) to medical treatment and surgery, and unresponsiveness (n = 13, n = 7). We examined the pathological slides of 86 women to determine the amount of hormone receptors and the relationship between the type of medical treatment and the level of hormone receptors on pain relief within 1 yr after surgery. Results: Based on the receiver operating characteristic curve, dysmenorrhea in the presence of tissue estrogen receptors > 60% (p = 0.1065), and dyspareunia in the presence of tissue progesterone receptors > 80% (p = 0.0001) responded well to medical treatment after surgery. In the presence of endometrioma-dysmenorrhea showed the best response to oral contraceptive pills (69.4%), while in deep infiltrative endometriosis-dyspareunia showed the best response to progesterone treatment (75%). Conclusion: Prescribing an appropriate hormone therapy based on a specific immunohistochemistry staining pattern can improve the life quality of postoperative endometriosis individuals.https://doi.org/10.18502/ijrm.v22i7.16970endometriosis, estrogen receptor, progesterone receptor, recurrence.
spellingShingle Tahereh Poordast
Saeed Alborzi
Ziba Kiani
Navid Omidifar
Elham Askary
Kefayat Chamanara
Mansoureh Shokripour
Alimohammad Keshtvarz Hesam Abadi
The role of progesterone and estrogen receptors in treatment choice after endometriosis surgery: A cross-sectional study
International Journal of Reproductive BioMedicine
endometriosis, estrogen receptor, progesterone receptor, recurrence.
title The role of progesterone and estrogen receptors in treatment choice after endometriosis surgery: A cross-sectional study
title_full The role of progesterone and estrogen receptors in treatment choice after endometriosis surgery: A cross-sectional study
title_fullStr The role of progesterone and estrogen receptors in treatment choice after endometriosis surgery: A cross-sectional study
title_full_unstemmed The role of progesterone and estrogen receptors in treatment choice after endometriosis surgery: A cross-sectional study
title_short The role of progesterone and estrogen receptors in treatment choice after endometriosis surgery: A cross-sectional study
title_sort role of progesterone and estrogen receptors in treatment choice after endometriosis surgery a cross sectional study
topic endometriosis, estrogen receptor, progesterone receptor, recurrence.
url https://doi.org/10.18502/ijrm.v22i7.16970
work_keys_str_mv AT taherehpoordast theroleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT saeedalborzi theroleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT zibakiani theroleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT navidomidifar theroleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT elhamaskary theroleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT kefayatchamanara theroleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT mansourehshokripour theroleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT alimohammadkeshtvarzhesamabadi theroleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT taherehpoordast roleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT saeedalborzi roleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT zibakiani roleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT navidomidifar roleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT elhamaskary roleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT kefayatchamanara roleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT mansourehshokripour roleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy
AT alimohammadkeshtvarzhesamabadi roleofprogesteroneandestrogenreceptorsintreatmentchoiceafterendometriosissurgeryacrosssectionalstudy